Biopharmaceuticals

Bears management the inventory marketplace for now, however these takeover performs can maintain the bulls glad

Reata’s inventory practically triples after FDA approves rare-disease drug amid uncertainty about strategy to neuroscience remedies

Seagen’s inventory soars on reported Pfizer buyout curiosity; Union Pacific shares rally after CEO ouster

Pfizer eyes takeover of biotech Seagen, at worth of greater than $30 billion

Why Botox and different beauty injections could also be resilient towards financial uncertainty

AstraZeneca says Forxiga accredited in EU for coronary heart failure